Novo Nordisk A/S ADR (NVO) Stock Price, Quote & News - Mboum

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The c...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 45 44 44 88 88

Website: www.novonordisk.com

Address:

Novo Alle 1, Bagsvaerd, Denmark

StocktwitsNews Aug. 19 at 10:38 AM

Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-looks-to-expand-wegovy-pill-push-with-lower-dose-study/cZYdgkhRJkA

0 · Reply

NorthstarT1D Aug. 19 at 8:17 AM

$NVO reinvested my dividend on the dip after this news: https://www.bloomberg.com/news/articles/2026-08-19/novo-starts-testing-low-dose-wegovy-pills-in-new-obesity-study

0 · Reply

Pseudominds Aug. 19 at 1:18 AM

$NVO 😂

0 · Reply

ContrarianLife Aug. 18 at 11:31 PM

$NVO Of course, Lilly up 2x today. It’s comical at this point. Who the F is buying Lilly at this point? Make that make ANY sense.

0 · Reply

BubbleBanker Aug. 18 at 10:44 PM

$NVO Time to accumulate and NOT write covered calls.

1 · Reply

Hooooooold Aug. 18 at 10:30 PM

$NVO FIRST amylin to market! Wooot another first!

0 · Reply

SniperPro Aug. 18 at 7:28 PM

$LXRX Yep, nice green candles despite the dark pool trying to shit all over our parade. 🟢🕯️📈 $BLK $STT $VOO $NVO 🤑💪 That said, I believe there are other big tutes quietly loading up for the next couple of weeks. 👀💰 They’re following the smart money — BlackRock, State Street, and the rest of the big boys. So who are you gonna believe? 🤔 Some broke-ass shorties screaming FUD from the sidelines… or the financial institutions that basically own Wall Street? 😂🏦 I know where I’m putting my chips. I go where the winners go. 🐂🚀 Shorts can keep fighting the tape while the institutions keep stacking. Let them get squeezed. 😈🔥 Just my 2 cents. 💎🙌📈 ...

0 · Reply

dontbesoconfident Aug. 18 at 7:20 PM

$NVO are we stuck in this range because of the ongoing shares buyback program?

1 · Reply

texas__red Aug. 18 at 6:47 PM

$NVO FOMO !!!!!

0 · Reply

Jtlo Aug. 18 at 5:30 PM

$NVO they will start chasing when it's over 50 running to 60

0 · Reply

Latest News on NVO

Novo begins study to find lowest effective dose for Wegovy pill

Wed, 19 Aug 2026 05:29:10 -0400 - 2 hours ago

Novo begins study to find lowest effective dose for Wegovy pill

Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss Pills

2026-08-18T16:39:49.000Z - 19 hours ago

Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss Pills

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now

2026-08-18T13:48:08.000Z - 22 hours ago

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now

Novo Nordisk downgraded to Hold from Buy at Berenberg

2026-08-17T11:03:43.000Z - 2 days ago

Novo Nordisk downgraded to Hold from Buy at Berenberg

Novo Nordisk downgraded to Hold from Buy at Berenberg

2026-08-17T10:23:20.000Z - 2 days ago

Novo Nordisk downgraded to Hold from Buy at Berenberg

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)

2026-08-14T22:30:00.000Z - 4 days ago

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)

Novo Nordisk Escalates Weight-Loss War With Eli Lilly

2026-08-13T17:32:27.000Z - 5 days ago

Novo Nordisk Escalates Weight-Loss War With Eli Lilly

Is Novo Nordisk's Wegovy-Fueled Rebound Evaporating?

Thu, 13 Aug 2026 13:00:00 -0400 - 5 days ago

Is Novo Nordisk's Wegovy-Fueled Rebound Evaporating?

Novo Nordisk Stock Slips as Pill Strategy Reframes Obesity Race

2026-08-13T16:11:52.000Z - 5 days ago

Novo Nordisk Stock Slips as Pill Strategy Reframes Obesity Race

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

2026-08-13T14:52:11.000Z - 5 days ago

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

Novo Nordisk Stock (NVO) Falls as CEO Weighs In on Obesity Drug Rivalry with Eli Lilly

2026-08-13T12:43:16.000Z - 5 days ago

Novo Nordisk Stock (NVO) Falls as CEO Weighs In on Obesity Drug Rivalry with Eli Lilly

Novo CEO says obesity market won’t be winner-take-all battle with Lilly

2026-08-13T12:26:04.888Z - 5 days ago

Novo CEO says obesity market won’t be winner-take-all battle with Lilly

Novo CEO says obesity market won't be winner-take-all battle with Lilly

Thu, 13 Aug 2026 06:01:53 -0400 - 6 days ago

Novo CEO says obesity market won't be winner-take-all battle with Lilly

Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer

Wed, 12 Aug 2026 20:04:45 -0400 - 6 days ago

Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer

Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer

2026-08-12T23:46:55.000Z - 6 days ago

Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer

Competition has to be fierce, but competition also has to be fair, says Novo Nordisk CEO Doustdar

2026-08-12T23:46:13.000Z - 6 days ago

Competition has to be fierce, but competition also has to be fair, says Novo Nordisk CEO Doustdar

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

Wed, 12 Aug 2026 18:53:21 -0400 - 6 days ago

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

Novo Nordisk CEO sees ‘long runway' for weight-loss drugs as obesity grips America

Wed, 12 Aug 2026 12:11:48 -0400 - 6 days ago

Novo Nordisk CEO sees ‘long runway' for weight-loss drugs as obesity grips America

Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market

2026-08-12T14:56:50.000Z - 6 days ago

Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market

PHARMA BETS: CEO turns to AI for next-generation drugs

Wed, 12 Aug 2026 10:30:00 -0400 - 6 days ago

PHARMA BETS: CEO turns to AI for next-generation drugs

Novo Nordisk Stock: Buy or Sell?

Tue, 11 Aug 2026 22:42:05 -0400 - 7 days ago

Novo Nordisk Stock: Buy or Sell?

Better Buy: Eli Lilly vs. Novo Nordisk

Tue, 11 Aug 2026 20:00:00 -0400 - 7 days ago

Better Buy: Eli Lilly vs. Novo Nordisk

Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

2026-08-11T09:27:44.000Z - 8 days ago

Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

Novo Nordisk A/S Q2 Earnings Call Highlights

Sat, 08 Aug 2026 18:05:10 -0400 - 10 days ago

Novo Nordisk A/S Q2 Earnings Call Highlights

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Fri, 07 Aug 2026 18:30:00 -0400 - 11 days ago

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

2026-08-07T19:28:00.000Z - 11 days ago

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound

Novo Nordisk Stock Rises After GLP-1 Antitrust Win

2026-08-07T16:41:44.000Z - 11 days ago

Novo Nordisk Stock Rises After GLP-1 Antitrust Win

Novo Nordisk price target lowered to DKK 310 from DKK 330 at Citi

2026-08-07T10:45:36.000Z - 12 days ago

Novo Nordisk price target lowered to DKK 310 from DKK 330 at Citi

Lilly, Novo defeat antitrust lawsuit over GLP‑1 drug market

2026-08-06T21:52:46.082Z - 12 days ago

Lilly, Novo defeat antitrust lawsuit over GLP‑1 drug market

Omnicom Wins U.S. Media Account for Ozempic and Wegovy Maker Novo Nordisk

2026-08-06T19:01:06.000Z - 12 days ago

Omnicom Wins U.S. Media Account for Ozempic and Wegovy Maker Novo Nordisk

Why Is Everyone Talking About Novo Nordisk?

Thu, 06 Aug 2026 15:00:00 -0400 - 12 days ago

Why Is Everyone Talking About Novo Nordisk?

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Thu, 06 Aug 2026 09:45:29 -0400 - 12 days ago

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

33 stocks to bet on foreign markets continuing to beat the S&P 500

Thu, 06 Aug 2026 07:30:00 -0400 - 13 days ago

33 stocks to bet on foreign markets continuing to beat the S&P 500

Novo Nordisk price target raised to $47 from $45 at BMO Capital

2026-08-06T11:25:51.000Z - 13 days ago

Novo Nordisk price target raised to $47 from $45 at BMO Capital

How Novo Nordisk's CEO Says He Is Shifting the Company's Perspective

Thu, 06 Aug 2026 05:49:00 -0400 - 13 days ago

How Novo Nordisk's CEO Says He Is Shifting the Company's Perspective

Bank of America CEO Says The Company Spends $250 Million A Year on GLP-1 Drugs for Their Employees. He Calls It a Good Investment

2026-08-05T23:20:01.000Z - 13 days ago

Bank of America CEO Says The Company Spends $250 Million A Year on GLP-1 Drugs for Their Employees. He Calls It a Good Investment

Novo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook

2026-08-05T18:30:23.000Z - 13 days ago

Novo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook

European Stocks Subdued as HSBC and Novo Nordisk Lead Declines

2026-08-05T17:24:14.000Z - 13 days ago

European Stocks Subdued as HSBC and Novo Nordisk Lead Declines

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

Wed, 05 Aug 2026 12:52:00 -0400 - 13 days ago

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

Novo Nordisk Wins Dutch Court Injunction Against Compounded Semaglutide Nasal Spray

2026-08-05T16:27:04.000Z - 13 days ago

Novo Nordisk Wins Dutch Court Injunction Against Compounded Semaglutide Nasal Spray

Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside

2026-08-05T14:45:33.000Z - 13 days ago

Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside

Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case

Aug 5, 2026, 9:57 AM EDT - 13 days ago

Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case

Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

Aug 5, 2026, 9:05 AM EDT - 13 days ago

Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

Novo Nordisk Earnings Call Transcript: Q2 2026

Aug 5, 2026, 7:00 AM EDT - 14 days ago

Novo Nordisk Earnings Call Transcript: Q2 2026

Novo Nordisk Quarterly report: Q2 2026

Aug 5, 2026, 7:00 AM EDT - 14 days ago

Novo Nordisk Quarterly report: Q2 2026

Novo Nordisk Slides: Q2 2026

Aug 5, 2026, 7:00 AM EDT - 14 days ago

Novo Nordisk Slides: Q2 2026

Novo Nordisk (NVO) Raises Guidance Amid Mixed Market Reactions

2026-08-05T10:32:28.000Z - 14 days ago

Novo Nordisk (NVO) Raises Guidance Amid Mixed Market Reactions

Novo Nordisk CEO addresses investors' high Wegovy pill expectations

Aug 5, 2026, 5:01 AM EDT - 14 days ago

Novo Nordisk CEO addresses investors' high Wegovy pill expectations

Novo Nordisk CEO addresses investors' high Wegovy pill expectations

2026-08-05T08:27:18.000Z - 14 days ago

Novo Nordisk CEO addresses investors' high Wegovy pill expectations

Novo Nordisk's raised forecast fails to change the debate over its obesity business

Aug 5, 2026, 2:11 AM EDT - 14 days ago

Novo Nordisk's raised forecast fails to change the debate over its obesity business

Novo CEO faces investor grilling after outlook hike soured by pipeline concerns

Aug 5, 2026, 1:59 AM EDT - 14 days ago

Novo CEO faces investor grilling after outlook hike soured by pipeline concerns

Novo Nordisk AS (NVO) Shares Fall 6.0% -- What GF Score of 75 Tells Investors

2026-08-04T22:23:50.000Z - 14 days ago

Novo Nordisk AS (NVO) Shares Fall 6.0% -- What GF Score of 75 Tells Investors

Portal Innovations CEO John Flavin: Novo Nordisk is undervalued

2026-08-04T21:57:29.000Z - 14 days ago

Portal Innovations CEO John Flavin: Novo Nordisk is undervalued

The Wegovy pill's ‘surprise miss' is one reason Novo Nordisk's stock is down

Aug 4, 2026, 4:01 PM EDT - 14 days ago

The Wegovy pill's ‘surprise miss' is one reason Novo Nordisk's stock is down

Novo Nordisk stock falls despite outlook hike as Wegovy sales miss hopes

Aug 4, 2026, 3:08 PM EDT - 14 days ago

Novo Nordisk stock falls despite outlook hike as Wegovy sales miss hopes

Novo Nordisk Raises Earnings Guidance. The Stock Sinks.

Aug 4, 2026, 2:16 PM EDT - 14 days ago

Novo Nordisk Raises Earnings Guidance. The Stock Sinks.

Novo Nordisk shares slide after guidance disappoints investors

Aug 4, 2026, 1:30 PM EDT - 14 days ago

Novo Nordisk shares slide after guidance disappoints investors

Wegovy Maker Novo Nordisk Lifts Guidance After Second-Quarter Boost

Aug 4, 2026, 1:03 PM EDT - 14 days ago

Wegovy Maker Novo Nordisk Lifts Guidance After Second-Quarter Boost

Novo Nordisk's Q2 profit beats forecasts, raises outlook

Aug 4, 2026, 12:41 PM EDT - 14 days ago

Novo Nordisk's Q2 profit beats forecasts, raises outlook

Obesity battle heats up again as Novo claws way back into race with Lilly

Aug 3, 2026, 1:02 AM EDT - 16 days ago

Obesity battle heats up again as Novo claws way back into race with Lilly

Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial

Jul 31, 2026, 11:15 AM EDT - 18 days ago

Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial

Novo Nordisk Stock Drops as Heart Drug Fails Late-Stage Trial

Jul 31, 2026, 10:56 AM EDT - 18 days ago

Novo Nordisk Stock Drops as Heart Drug Fails Late-Stage Trial

Novo Nordisk's stock slumps after failed trial — adding to the company's woes

Jul 31, 2026, 9:54 AM EDT - 18 days ago

Novo Nordisk's stock slumps after failed trial — adding to the company's woes

Novo Nordisk Stock Sinks on Disappointing Heart Drug Trial Results

Jul 31, 2026, 9:17 AM EDT - 18 days ago

Novo Nordisk Stock Sinks on Disappointing Heart Drug Trial Results

Novo Nordisk Shares Drop After Drug Candidate Fails in Cardiovascular Trial

Jul 31, 2026, 8:02 AM EDT - 18 days ago

Novo Nordisk Shares Drop After Drug Candidate Fails in Cardiovascular Trial

Novo Nordisk shares dive 9% after heart medicine fails trial

Jul 31, 2026, 7:43 AM EDT - 19 days ago

Novo Nordisk shares dive 9% after heart medicine fails trial

Novo Nordisk's inflammation drug fails to reduce cardiovascular risk in trial

Jul 31, 2026, 7:34 AM EDT - 19 days ago

Novo Nordisk's inflammation drug fails to reduce cardiovascular risk in trial

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Jul 29, 2026, 9:11 AM EDT - 20 days ago

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial

Jul 28, 2026, 1:00 PM EDT - 21 days ago

Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial

As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize

Jul 24, 2026, 9:09 AM EDT - 25 days ago

As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize

Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads

Jul 24, 2026, 5:48 AM EDT - 26 days ago

Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads

Novo Nordisk seeks preliminary injunction against Lilly weight-loss ads

Jul 24, 2026, 4:41 AM EDT - 26 days ago

Novo Nordisk seeks preliminary injunction against Lilly weight-loss ads

Crux Collaborates with Novo Nordisk to Offer Access to Wegovy® and Other Obesity Management Medications

Jul 23, 2026, 9:01 AM EDT - 26 days ago

Crux Collaborates with Novo Nordisk to Offer Access to Wegovy® and Other Obesity Management Medications

Weight loss drugs linked to increase risk of hair loss

Jul 22, 2026, 8:57 PM EDT - 27 days ago

Weight loss drugs linked to increase risk of hair loss

Hair loss with GLP-1 drugs is rare, but real, studies find

Jul 22, 2026, 6:31 PM EDT - 27 days ago

Hair loss with GLP-1 drugs is rare, but real, studies find

Many US patients opt for obesity drug injections, defying some expectations

Jul 22, 2026, 6:06 AM EDT - 4 weeks ago

Many US patients opt for obesity drug injections, defying some expectations

Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising

Jul 21, 2026, 10:29 AM EDT - 4 weeks ago

Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising

Novo Sues Rival Lilly Over Weight-Loss Ads

Jul 21, 2026, 10:21 AM EDT - 4 weeks ago

Novo Sues Rival Lilly Over Weight-Loss Ads

Novo Nordisk Sues GLP-1 Rival Eli Lilly For Misleading Advertising

Jul 21, 2026, 9:15 AM EDT - 4 weeks ago

Novo Nordisk Sues GLP-1 Rival Eli Lilly For Misleading Advertising

Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

Jul 21, 2026, 8:33 AM EDT - 4 weeks ago

Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Jul 21, 2026, 8:18 AM EDT - 4 weeks ago

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugs

Jul 21, 2026, 7:58 AM EDT - 4 weeks ago

Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugs

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Jul 21, 2026, 7:38 AM EDT - 4 weeks ago

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Jul 21, 2026, 7:35 AM EDT - 4 weeks ago

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

One in Every Five U.S. Homes Using GLP-1s: What it Means for Consumer Trends

Jul 18, 2026, 4:00 PM EDT - 4 weeks ago

One in Every Five U.S. Homes Using GLP-1s: What it Means for Consumer Trends

Novo Nordisk to launch lower-cost Ozempic copy in South Africa

Jul 17, 2026, 12:20 PM EDT - 4 weeks ago

Novo Nordisk to launch lower-cost Ozempic copy in South Africa

India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease

Jul 17, 2026, 4:39 AM EDT - 4 weeks ago

India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease

Novo Nordisk wins EU approval for Wegovy weight-loss pill

Jul 15, 2026, 12:40 PM EDT - 4 weeks ago

Novo Nordisk wins EU approval for Wegovy weight-loss pill

StocktwitsNews Aug. 19 at 10:38 AM

Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-looks-to-expand-wegovy-pill-push-with-lower-dose-study/cZYdgkhRJkA

0 · Reply

NorthstarT1D Aug. 19 at 8:17 AM

$NVO reinvested my dividend on the dip after this news: https://www.bloomberg.com/news/articles/2026-08-19/novo-starts-testing-low-dose-wegovy-pills-in-new-obesity-study

0 · Reply

Pseudominds Aug. 19 at 1:18 AM

$NVO 😂

0 · Reply

ContrarianLife Aug. 18 at 11:31 PM

$NVO Of course, Lilly up 2x today. It’s comical at this point. Who the F is buying Lilly at this point? Make that make ANY sense.

0 · Reply

BubbleBanker Aug. 18 at 10:44 PM

$NVO Time to accumulate and NOT write covered calls.

1 · Reply

Hooooooold Aug. 18 at 10:30 PM

$NVO FIRST amylin to market! Wooot another first!

0 · Reply

SniperPro Aug. 18 at 7:28 PM

$LXRX Yep, nice green candles despite the dark pool trying to shit all over our parade. 🟢🕯️📈 $BLK $STT $VOO $NVO 🤑💪 That said, I believe there are other big tutes quietly loading up for the next couple of weeks. 👀💰 They’re following the smart money — BlackRock, State Street, and the rest of the big boys. So who are you gonna believe? 🤔 Some broke-ass shorties screaming FUD from the sidelines… or the financial institutions that basically own Wall Street? 😂🏦 I know where I’m putting my chips. I go where the winners go. 🐂🚀 Shorts can keep fighting the tape while the institutions keep stacking. Let them get squeezed. 😈🔥 Just my 2 cents. 💎🙌📈 ...

0 · Reply

dontbesoconfident Aug. 18 at 7:20 PM

$NVO are we stuck in this range because of the ongoing shares buyback program?

1 · Reply

texas__red Aug. 18 at 6:47 PM

$NVO FOMO !!!!!

0 · Reply

Jtlo Aug. 18 at 5:30 PM

$NVO they will start chasing when it's over 50 running to 60

0 · Reply

Baxter5 Aug. 18 at 5:22 PM

$NVO dead cat bounce Before under 40

1 · Reply

Wallst45 Aug. 18 at 5:07 PM

$NVO nice pop today lol 😂

0 · Reply

Makingmillions192 Aug. 18 at 4:55 PM

$LEXX Rani ran to a 250m mkt cap on their deal at the end of 2025. Not out of the question to say we can 10x from here if the existing MTA partner structures something similar. Very exciting 💰 $RANI $LLY $VKTX $NVO

0 · Reply

Yass93 Aug. 18 at 4:43 PM

$NVO This would need to move 20%+ upwards for it to be anything noteworthy. It was 10%+ higher a month ago and 30% higher earlier this year.

0 · Reply

m1gls Aug. 18 at 4:07 PM

0 · Reply

Penki1985 Aug. 18 at 3:44 PM

$NVO chance for double bottom here?

0 · Reply

Oldmoneycashhoney Aug. 18 at 3:07 PM

$NVO if this 50 we should see 60 EOY

0 · Reply

Jtlo Aug. 18 at 2:41 PM

$NVO we grovy baby

0 · Reply

JacoI3 Aug. 18 at 2:27 PM

$NVO I just bought a LLY share to give us an edge. It should be back at 800 eow.

1 · Reply

LadsAndGents Aug. 18 at 2:25 PM

$NVO when 60plus, Oct - Nov ? $XBI

0 · Reply

QuietTrader Aug. 18 at 2:11 PM

Stocks to watch today: $LMND $BMY $NVO $DEO Yup, they’re cool again! 😉

0 · Reply

Asrieljp Aug. 18 at 1:59 PM

$NVO looks like we ran out of sellers and things calmed after divi... there was solid volume of shorters past like 2 weeks... they will provide buying pressure most likely for the immediate future.

0 · Reply